Posted on 4/11/19
DrugPatentWatch Partners with Adis
DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis' market-leading platform, bringing together the most . . .
Posted on 4/11/19
StageBio and Tox Path Specialists Merge
StageBio has merged with Tox Path Specialists, LLC (TPS) to create the leading provider of research and preclinical
Posted on 4/10/19
Rexahn Announces Reverse Stock Split
ROCKVILLE, Md., April 10, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in . . .
Posted on 4/10/19
Merkle/HelloWorld Named a Strong Performer among Loyalty Technology Solutions
COLUMBIA, Md.--(BUSINESS WIRE)--Merkle (www.merkleinc.com), a leading technology-enabled, data-driven performance marketing agency, announced that Forrester Research, Inc., an independent research firm, ranked Merkle/HelloWorld as a Strong Performer . . .
Posted on 4/10/19
Rock Springs Capital and NEA Join $67M Series A2 For Inozyme Pharma
Inozyme Pharma, Inc., a biotechnology company developing novel medicines to treat rare, debilitating, and life-threatening mineralization disorders
Posted on 4/9/19
ACHF and Aetna Student Health Collaborate
As student health and wellness expands beyond traditional disease prevention to encompass more holistic and cooperative solutions, the American College Health Foundation (ACHF) announces its collaborative . . .
Posted on 4/9/19
Harvest Health & Recreation To Acquire CannaPharmacy
Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S.,
Posted on 4/8/19
National Science Teachers Association Announces Recipients of its 2019 Teacher Awards Program
ARLINGTON, Va.--(BUSINESS WIRE)--The National Science Teachers Association (NSTA) announced the winners of the 2019 NSTA Teacher Awards program, which honors K–12 teachers, principals, professors and other . . .
Posted on 4/8/19
Ascentage Pharma Announces Clinical Collaboration with Junshi Bioscience
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B and age-related diseases,today announced that it has entered into a . . .
Posted on 4/4/19
Osiris Therapeutics Is Undervalued In Buyout
Summary While Osiris Therapeutics has appreciated 40% this year to $19, it is still undervalued. We forecast sales to rise greater than 20% in 2019, after . . .
Posted on 4/2/19
Merkle Releases Amazon Advertising Flywheel Strategy Guide
COLUMBIA, Md.--(BUSINESS WIRE)--Merkle (www.merkleinc.com), a leading technology-enabled, data-driven performance marketing agency, today released its second annual Amazon Ads Playbook. This year’s report, titled “The Amazon Advertising . . .
Posted on 4/1/19
Doctors Community Hospital Awarded $3.5 Million Healthcare Grant
Doctors Community Hospital was awarded a $3.5 million grant from the Maryland Department of Health’s Center for Cancer Prevention and Control. This three-year grant will provide . . .
Posted on 4/1/19
Armed Services YMCA and Department of Defense Reach Agreement to Provide Fitness Options
Armed Services YMCA and the Department of Defense are announcing the continuation of the DOD Military Outreach Initiative. This joint effort provides eligible DoD service members . . .
Posted on 3/31/19
OpGen Closes Public Offering of Common Stock
GAITHERSBURG, Md., March 29, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today the closing of its previously announced underwritten public offering of 9 million . . .
Posted on 3/28/19
Orgenesis Signs Master Service and Joint Venture Agreement with TheraCell Advanced Biotechnology
GERMANTOWN, Md., March 28, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced that it . . .
Posted on 3/26/19
OpGen Prices $5.4 Million Public Offering of Common Stock
GAITHERSBURG, Md., March 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today the pricing of an underwritten public offering of 9 million shares of . . .
Posted on 3/25/19
Orgenesis Subsidiary Masthercell Global Announces Plans to Establish New Facility
GERMANTOWN, Md., March 25, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced plans to . . .
Posted on 3/25/19
Bloomberg Environment Announces Expanded And Enhanced Flagship EHS Compliance Solution
Bloomberg Environment announced today the launch of its next generation compliance solution for Environment, Health & Safety (EHS) professionals, which offers new features and expanded content. . . .
Posted on 3/25/19
2019’s Best & Worst States for Doctors – WalletHub Study
Doctors are among the highest-paid and most educated professionals in the U.S. In fact, “physician” was the highest-paid job type in 2018, with a median base . . .
Posted on 3/25/19
Novavax: Hope Abounds
Summary Novavax's RSV program is running on fumes; however, it still has value. Novavax's flu program remains unsullied but unloved. Deals are in the wind. Dilution . . .
Posted on 3/21/19
Why Novavax Is Soaring Today
What happenedShares of Novavax (NASDAQ:NVAX) were soaring 14.6% higher as of 11:23 a.m. EDT on Wednesday after jumping as much as 25.5% higher earlier in the . . .
Posted on 3/21/19
Does Novavax Have a Viable Path Forward?
Novavax (NASDAQ:NVAX), a pre-revenue vaccine developer, is stuck between a rock and a hard place. Following the latest clinical failure of its respiratory syncytial virus (RSV) . . .
Posted on 3/21/19
What's Next for Novavax?
You might think it could be game over for Novavax (NASDAQ:NVAX) after the clinical-stage biotech reported its second late-stage failure for experimental respiratory syncytial virus (RSV) . . .
Posted on 3/20/19
Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership
HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced an extension of its partnership with Takeda Pharmaceutical Company Limited to discover and develop additional novel . . .
Posted on 3/20/19
PCTEST Expands 5G NR and LTE Device Testing Capabilities with Rohde & Schwarz
PCTEST Engineering Laboratory, Inc. (PCTEST), a premier testing laboratory for wireless device testing including certification and R&D test, has selected the R&S CMX500 and R&S CMW500 . . .

